Cardio-Oncology Education and Training: JACC Council Perspectives.
cancer
cardio-oncology
cardiotoxicity
training
Journal
Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365
Informations de publication
Date de publication:
10 11 2020
10 11 2020
Historique:
received:
11
06
2020
revised:
12
08
2020
accepted:
28
08
2020
entrez:
6
11
2020
pubmed:
7
11
2020
medline:
17
2
2021
Statut:
ppublish
Résumé
The innovative development of cancer therapies has led to an unprecedented improvement in survival outcomes and a wide array of treatment-related toxicities, including those that are cardiovascular in nature. Aging of the population further adds to the number of patients being treated for cancer, especially those with comorbidities. Such pre-existing and developing cardiovascular diseases pose some of the greatest risks of morbidity and mortality in patients with cancer. Addressing the complex cardiovascular needs of these patients has become increasingly important, resulting in an imperative for an intersecting discipline: cardio-oncology. Over the past decade, there has been a remarkable rise of cardio-oncology clinics and service lines. This development, however, has occurred in a vacuum of standard practice and training guidelines, although these are being actively pursued. In this council perspective document, the authors delineate the scope of practice in cardio-oncology and the proposed training requirements, as well as the necessary core competencies. This document also serves as a roadmap toward confirming cardio-oncology as a subspecialty in medicine.
Identifiants
pubmed: 33153587
pii: S0735-1097(20)37191-6
doi: 10.1016/j.jacc.2020.08.079
pmc: PMC8174559
mid: NIHMS1663276
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2267-2281Subventions
Organisme : NCI NIH HHS
ID : R01 CA233601
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA233610
Pays : United States
Informations de copyright
Copyright © 2020. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Author Relationship With Industry Dr. Zaha is supported by The Cancer Prevention Research Institute of Texas award RP18040. Dr. Mitchell is supported by the Children’s Discovery Institute and Longer Life Foundation. Dr. Herrmann is supported by the National Institutes of Health/National Cancer Institute grant R01CA233601 and the Miami/Florida Heart Research Foundation. Dr. Mitchell has received research funds from Pfizer. Dr. Barac has been on the advisory board of Takeda Ariad Pharmaceuticals. Dr. Dent has grant funding from Novartis US; and has received consultant fees from Novartis Canada. Dr. Lenihan has been a consultant to Lilly, Acorda, Bristol Myers Squibb, and Roche; and has received research funding from Myocardial Solutions. Dr. Herrmann has been a consultant to Amgen, Bristol Myers Squibb, and Takeda (Ariad) Pharmaceuticals. None of these are directly related to the current work.
Références
Lancet. 2019 Sep 21;394(10203):986-988
pubmed: 31443925
Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):88-93
pubmed: 20728695
Ann Thorac Surg. 1999 Nov;68(5):1827-31
pubmed: 10585066
Clin Pharmacol Ther. 2018 Apr;103(4):540-544
pubmed: 29527663
Int J Cardiol. 2017 Aug 15;241:387-392
pubmed: 28365180
J Am Coll Cardiol. 2018 Apr 10;71(14):1584-1589
pubmed: 29622166
J Am Coll Cardiol. 2019 Nov 5;74(18):2322-2325
pubmed: 31672189
J Am Coll Cardiol. 2015 Jun 16;65(23):2511-22
pubmed: 26065990
J Am Soc Echocardiogr. 2014 Sep;27(9):911-39
pubmed: 25172399
J Am Coll Cardiol. 2000 Aug;36(2):517-22
pubmed: 10933366
JACC Cardiovasc Imaging. 2018 Aug;11(8):1150-1172
pubmed: 30092971
J Am Coll Cardiol. 2018 Apr 17;71(15):1707-1709
pubmed: 29551219
J Am Coll Cardiol. 2018 Apr 24;71(16):1755-1764
pubmed: 29567210
Am J Cardiol. 2016 Feb 15;117(4):691-696
pubmed: 26772441
J Am Coll Cardiol. 2017 Nov 28;70(21):2723-2726
pubmed: 29169480
Eur Heart J. 2019 Dec 21;40(48):3889-3897
pubmed: 31761945
J Am Coll Cardiol. 2003 Aug 20;42(4):743-9
pubmed: 12932613
J Am Coll Cardiol. 2019 May 7;73(17):2226-2235
pubmed: 31047011
J Clin Oncol. 2013 Oct 10;31(29):3673-80
pubmed: 24002505
Curr Oncol. 2019 Jun;26(3):e322-e327
pubmed: 31285675
J Am Soc Echocardiogr. 2013 Sep;26(9):1013-32
pubmed: 23998694
J Am Coll Cardiol. 2019 Dec 24;74(25):3099-3108
pubmed: 31856966
Eur J Heart Fail. 2018 Dec;20(12):1721-1731
pubmed: 30191649
J Oncol Pract. 2019 Aug;15(8):e652-e665
pubmed: 31306039
Circulation. 2016 Mar 15;133(11):1104-14
pubmed: 26976915
J Am Coll Cardiol. 2015 May 5;65(17):1734-53
pubmed: 25777647
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Curr Treat Options Cardiovasc Med. 2018 Apr 7;20(5):40
pubmed: 29627870
Eur Heart J. 2019 Jun 7;40(22):1756-1763
pubmed: 30085070
Ann Oncol. 2020 Feb;31(2):171-190
pubmed: 31959335
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
J Am Coll Cardiol. 2019 Oct 1;74(13):1714-1727
pubmed: 31558256
JACC Cardiovasc Imaging. 2018 Aug;11(8):1084-1093
pubmed: 30092967
J Card Fail. 2016 Jun;22(6):465-71
pubmed: 27038642
J Am Coll Cardiol. 2019 Nov 5;74(18):2325
pubmed: 31672190
J Am Coll Cardiol. 2019 Oct 15;74(15):1926-1942
pubmed: 31601373
J Am Coll Cardiol. 2018 Jun 26;71(25):2977-2981
pubmed: 29929621
J Am Coll Cardiol. 2019 Jun 11;73(22):2896-2899
pubmed: 31171096
J Clin Oncol. 2012 Oct 20;30(30):3657-64
pubmed: 23008297
Am J Cardiol. 2013 Feb 15;111(4):609-12
pubmed: 23195041
J Am Coll Cardiol. 2018 Jun 26;71(25):2980-2981
pubmed: 29929622
J Heart Lung Transplant. 2012 Aug;31(8):805-10
pubmed: 22551930
JACC Cardiovasc Imaging. 2019 Dec;12(12):2505-2513
pubmed: 31806181
J Am Coll Cardiol. 2015 Jun 30;65(25):2739-46
pubmed: 26112199
J Clin Oncol. 2019 May 1;37(13):1090-1101
pubmed: 30860946
Mayo Clin Proc. 2016 Dec;91(12):1680-1692
pubmed: 27916154
J Am Coll Cardiol. 2018 Aug 21;72(8):948-951
pubmed: 30115233